Table 2 Baseline characteristics
Pre-COVID-19 period (n = 34) | COVID-19 period (n = 46) | P value | |
|---|---|---|---|
Age (year) | 70.8 ± 12.7 | 65.0 ± 12.8 | 0.04 |
Male gender (%) | 23 (64.8) | 28 (66.4) | 0.42 |
DM (%) | 24 (68.9) | 28 (65.5) | 0.74 |
Hypertension (%) | 17 (54.4) | 22 (48.7) | 0.27 |
IHD (%) | 10 (24.8) | 10 (28.6) | 0.39 |
CVA (%) | 8 (18.1) | 12 (16.8) | 0.85 |
Chronic kidney disease (%) | 9 (23.2) | 13 (31.1) | 0.93 |
Chronic lung disease (%) | 5 (12.0) | 7 (14.3) | 0.99 |
Chronic liver disease (%) | 1 (8.0) | 1 (5.8) | 0.81 |
Malignancy (%) | 6 (14.4) | 1 (8.4) | 0.01 |
APACHE II Score | 29.1 ± 10.1 | 29.3 ± 9.2 | 0.93 |
HCBT response time (min) | 2.45 ± 1.25 | 3.50 ± 2.12 | 0.01 |